Roivant establishes new business units, launches PAH company

Roivant Sciences GmbH (Basel, Switzerland) said it created two business units, Roivant Pharma and Roivant Health, and launched pulmonary arterial hypertension (PAH) company Altavant.

Roivant Pharma will focus on "end-to-end biopharmaceutical company creation in new therapeutic areas." Roivant Health will focus on "launching companies that bring innovative medicines to emerging markets and improve the process of developing and commercializing new medicines through the application of technology."...